The fact is there are many evidence-based, non-toxic therapies that kill prostate cancer. Further, there are many reasons why a man may want to slow or halt prostate cancer either in his prostate or in his blood stream after his prostate has been removed.
The problem with conventional prostate cancer therapies is that they come with a host of short, long-term and late stage side-effects. Modified Citrus Pectin does not. The reason why toxic therapies come with short, long-term and late stage side effects is because these therapies are stronger and often toxic. Therefore the prostate cancer survivor has choices to make. Choose an evidence-based, non-toxic therapy with no side effects that may be less effective or a toxic, FDA approved therapy than may kill your prostate cancer but kill healthy cells as well.
I’ve relied on evidence-based non-toxic therapies to maintain complete remission from my cancer since 1999. Therefore my experience as a long-term cancer survivor is favorable when it comes to non-toxic forms of evidence-based therapies. The article by Ralph Moss linked and excerpted below cites Pectasol and Pectasol-C as being cytotoxic to prostate cancer in test tubes.
While there needs to be more studies on modified citrus pectin as a cancer therapy I believe the comments below are a start for prostate cancer patients to consider this therapy.
I am both a long-term cancer survivor of an incurable cancer and a cancer coach. If you would like to learn more about cancer coaching and receive the Introduction my e-book “Curing Cancer-If I Knew Then What I Know Now…” for free, please scroll down the the page and post a question or a comment. I will reply to you ASAP.
“This week brought a major advance in understanding the effects of modified citrus pectin (MCP) on cancer cells. Scientists at Columbia University published a paper showing that MCP stops the growth of prostate cancer (PC) cells in the test tube. Most significantly this effect was seen in both hormone-dependent and hormone-independent forms of the disease. There are very few treatments for hormone- independent PC, and so a report of likely benefit from a simple nutritional agent is highly significant.
Dr. Jun Yan and Dr. Aaron Katz tested two versions of MCP, PectaSol and PectaSol-C, both invented by Dr. Isaac Eliaz. In general, the new form of product outperformed the earlier version. The authors looked at apoptosis (the most prevalent form of programmed cell death) as well as at the inhibition of cell growth. A one percent solution of PectaSol-C was toxic to five cell lines. After four days of treatment, the total destruction of cancer cells ranged from 23.0 to 52.2 percent. The authors concluded that PectaSol and PectaSol-C both inhibited cell proliferation and apoptosis in prostate cancer cell lines.”
“After non-melanoma skin cancer, prostate cancer is the most commonly diagnosed cancer in American men. It’s also highly treatable if caught early. For many men, though, the standard treatments for prostate cancer — medication, radiation, and surgery — often come with unwanted side effects.